A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)

NCT05705258 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinopathy of Prematurity
Newborns
Infants

Interventions

DRUG: Aflibercept (Eylea, BAY86-5321)

Sponsor

Bayer